# Zhejiang Pure Pharmaceutical Co., Ltd. – FDA Inspection, Apr 27, 2018

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-pure-pharmaceutical-co-ltd/fd507b15-651c-471e-8b7e-6a0bd1a2b788
Source feed: FDA_Inspections

> FDA inspection 1052811 of Zhejiang Pure Pharmaceutical Co., Ltd., April 27, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1052811
- Company Name: Zhejiang Pure Pharmaceutical Co., Ltd.
- Inspection Date: 2018-04-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Investigator](https://www.keypedia.com/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3)
- [FDA Associated Person](https://www.keypedia.com/people/joshua-p-wireman/1f5cca58-4a35-4b1a-b344-35820b1e58fb)

Company: https://www.keypedia.com/companies/zhejiang-pure-pharmaceutical-co-ltd/d74b8603-bac9-43b0-99b1-540c1253c81d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c